March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets cardiac MRI scans with performance approaching expert clinicians. Trained on ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
March 30, 2026 — Partho Sengupta, MD, DM, FACC, FASE, was honored as a 2026 Distinguished Scientist (Translational ...
March 28, 2026 — Medtronic has announced the EMBRACE trial, led by Dr. Roxana Mehran, Professor of Medicine and Director ...
March 28, 2026 — Randomized controlled trial (RCT) data presented at the American College of Cardiology (ACC) 2026 and ...
March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that ...
March 18, 2026  — UltraSight will present six clinical studies validating the performance of its UltraSight Echosystem ...
March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...
March 19, 2026 — Endovascular Engineering, Inc. has announced that two abstracts related to the ENGULF study and the ...
March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...
March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
Feb. 5, 2026 — New research shows that the use of an AI-enabled digital stethoscope more than doubled the identification ...
Feb. 6, 2026 — Rapid Medical, a developer of active endovascular devices, has announced the latest results from the ...
Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial ...
Feb. 3, 2026 — The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI ...
Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...
March 31, 2026